Lachnospiraceae
Discovering the Lachnospiraceae: A Keystone Genus in Gut Health and Beyond
Description
Lachnospiraceae, a prominent bacterial family within the gut microbiota, plays a crucial role in maintaining overall health and well-being. These microbes are Gram-negative, obligate anaerobes, showcasing a diverse range of metabolic capabilities, including carbohydrate fermentation and short-chain fatty acid (SCFA) production.
Associated Diseases
Research has linked imbalances in Lachnospiraceae to various health conditions, including:
- Inflammatory bowel disease (IBD): Reduced levels of Lachnospiraceae have been observed in individuals with IBD, contributing to intestinal inflammation and impaired immune function.
- Obesity: Certain Lachnospiraceae species are associated with reduced body weight and improved insulin sensitivity, suggesting their potential in combating obesity.
- Type 2 diabetes: Alterations in Lachnospiraceae abundance have been linked to insulin resistance and disrupted glucose metabolism, highlighting their role in diabetes development.
- Colon cancer: Increased levels of specific Lachnospiraceae species have been associated with a reduced risk of colon cancer, suggesting a protective effect against carcinogenesis.
Did you Know ?
Studies have shown that individuals with higher abundance of Lachnospiraceae in their gut microbiome have a 20% lower risk of developing metabolic syndrome, a cluster of conditions including hypertension, obesity, and high blood sugar.
